Comment on

• Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial.

  Mehta SR, Yusuf S, Díaz R, Zhu J, Pais P, Xavier D, Paolasso E, Ahmed R, Xie C, Kazmi K, Tai J, Orlandini A, Pogue J, Liu L; CREATE-ECLA Trial Group Investigators. Mehta SR, et al. JAMA. 2005 Jan 26;293(4):437-46. doi: 10.1001/jama.293.4.437. JAMA. 2005. PMID: 15671428 Clinical Trial.
• Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction.

  Díaz R, Goyal A, Mehta SR, Afzal R, Xavier D, Pais P, Chrolavicius S, Zhu J, Kazmi K, Liu L, Budaj A, Zubaid M, Avezum A, Ruda M, Yusuf S. Díaz R, et al. JAMA. 2007 Nov 28;298(20):2399-405. doi: 10.1001/jama.298.20.2399. JAMA. 2007. PMID: 18042917 Clinical Trial.